ATM kinase

ATM kinase
User:AtikaAtikawa · CC BY-SA 4.0 · source
Name	ATM kinase
Organism	Human
Length	~3,056 aa

ATM kinase ATM kinase is a large serine/threonine protein kinase central to the cellular response to DNA double-strand breaks and genomic stress. Discovered through genetic studies of human disease and molecular screens, it connects DNA damage detection to cell-cycle control, DNA repair, apoptosis, and transcriptional programs. ATM acts in coordination with many proteins and complexes that have been characterized across cellular, genetic, and biochemical studies.

Function and Biological Role

ATM kinase functions as a master regulator of the DNA damage response, mediating signaling cascades that preserve genomic integrity after insults such as ionizing radiation and oxidative stress. It phosphorylates key substrates involved in checkpoint control, including p53, BRCA1, CHK2, and H2AX, thereby coordinating DNA repair by homologous recombination and non-homologous end joining. ATM also modulates cell-cycle progression through interactions with the CDC25 phosphatases and the RB1 pathway, enforcing G1/S and G2/M checkpoints to prevent propagation of damaged DNA. Beyond canonical DNA repair, ATM influences cellular metabolism and oxidative stress responses through links to AMPK and mitochondrial regulators, and impacts immune development via signaling networks that intersect with RAG1-mediated recombination in lymphocytes.

Structure and Regulation

ATM kinase is a member of the phosphatidylinositol 3-kinase-related kinase (PIKK) family, sharing architectural features with DNA-PKcs, ATR, and mTOR. The protein comprises HEAT repeats in an N-terminal region that mediate protein-protein interactions, followed by a FAT domain, an autoinhibitory FATC motif at the C-terminus, and a catalytic kinase domain resembling that of PI3K. ATM exists predominantly as an inactive homodimer or higher-order multimer in unstressed cells; intermolecular interfaces stabilized by HEAT repeats and binding partners such as MRN complex components regulate its quaternary state. Post-translational modifications—autophosphorylation, acetylation by factors like Tip60, and ubiquitination mediated by ring finger E3 ligases—modulate ATM localization and activity. Interaction with chromatin remodelers including MRN complex and histone marks such as phosphorylated H2AX contributes to recruitment to sites of DNA damage.

Mechanism of Activation and Signaling Pathways

Activation of ATM kinase is triggered by recruitment to DNA double-strand breaks via the MRN complex (composed of MRE11, RAD50, and NBS1), which senses DNA ends and promotes conformational changes leading to monomerization and activation. Autophosphorylation at specific serine residues and acetylation by Tip60 further enhance catalytic activity. Activated ATM phosphorylates a broad substrate repertoire including CHK2, p53, BRCA1, NBS1, and proteins involved in chromatin dynamics such as KAP1. These phosphorylation events initiate signaling branches that regulate DNA repair pathway choice: promoting end resection and homologous recombination through effectors like CtIP and RAD51, or facilitating non-homologous end joining by modulating factors such as XRCC4. ATM also interfaces with checkpoint kinases and cell-cycle regulators including CDC25A, causing inhibitory phosphorylation and cell-cycle arrest. In addition to nuclear roles, ATM signaling extends to cytoplasmic pathways affecting autophagy, mitochondrial homeostasis via PINK1-related networks, and inflammatory signaling connected to NF-κB activation through adaptors like NEMO.

Clinical Significance and Diseases

Germline mutations in ATM kinase cause a multisystem disorder characterized by neurodegeneration, immunodeficiency, radiosensitivity, and cancer predisposition, with hallmark features documented in clinical genetics and neurology literature. Heterozygous ATM variants are associated with increased risk for breast cancer and pancreatic cancer in large cohort and consortium studies, influencing genetic counseling and surveillance strategies. Somatic ATM alterations are implicated in tumor biology across malignancies such as chronic lymphocytic leukemia, glioblastoma, and lung adenocarcinoma, where loss of ATM function affects responses to DNA-damaging chemotherapies and radiotherapy. ATM deficiency also alters sensitivity to targeted agents: tumors with impaired ATM signaling show synthetic lethal interactions with inhibitors of PARP and the ATR pathway, a principle exploited in oncology drug development and clinical trials. Moreover, ATM-related pathways intersect with aging research, as ATM influences telomere maintenance and cellular senescence studied in gerontology and cell biology.

Research Tools and Experimental Studies

A range of molecular and genetic tools enable interrogation of ATM kinase function. Knockout and conditional mouse models developed by genetics groups have elucidated roles in neurodevelopment and immune recombination. CRISPR/Cas9-mediated gene editing and siRNA screens in cell lines from laboratories working on DNA repair have mapped genetic interactions with ATM. Biochemical assays use recombinant ATM fragments and kinase assays to profile substrate specificity and inhibitor potency; small-molecule inhibitors such as KU-60019 and AZD0156 emerged from medicinal chemistry programs and are used in preclinical studies. Proteomics approaches including phosphoproteomics and mass spectrometry—employed by research consortia—identify ATM-dependent phosphorylation networks after ionizing radiation exposure. Structural biology efforts using cryo-electron microscopy and crosslinking mass spectrometry by structural biology groups have begun to resolve the large-scale architecture of ATM complexes, informing models of activation and drug targeting. Clinical translational studies integrate ATM status into precision oncology trials conducted by cooperative groups and cancer centers to evaluate targeted synthetic-lethal strategies.

Category:Protein kinases